SS
VTVT icon

SBI Securities’s vTv Therapeutics VTVT Stock Holding History

SBI Securities’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75 Hold
2
– – ﹤0.01% 3578
2026
Q1 		$79 Hold
2
– – ﹤0.01% 3470
2025
Q4 		$80 Hold
2
– – ﹤0.01% 3474
2025
Q3 		$47 Hold
2
– – ﹤0.01% 3742
2025
Q2 		$30 Sell
2
-8
-80% -$147 ﹤0.01% 3831
2025
Q1 		$173 Buy
+10
New +$167 ﹤0.01% 3271

Other funds holding VTVT

CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
VNA
Valley National Advisers Bethlehem, Pennsylvania $900M AUM 31.19% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

SBI Securities's VTVT Position: Q2 2026 in Review

SBI Securities held its vTv Therapeutics (VTVT) position steady in Q2 2026 at 2 shares worth $75. The position accounts for ﹤0.01% of the portfolio, ranked #3578.

SBI Securities first reported a position in VTVT in Q1 2025 and has held it in 6 quarters since. The position peaked at $173 in Q1 2025. 6 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • SBI Securities held 2 shares of vTv Therapeutics worth $75 as of Q2 2026.
  • SBI Securities left its vTv Therapeutics share count unchanged in Q2 2026.
  • vTv Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3578 holding.
  • SBI Securities first reported a position in vTv Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • SBI Securities's vTv Therapeutics position peaked at $173 in Q1 2025.
  • 6 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.